Treating hypertension in the patient with overt diabetic nephropathy

Area of Science:

• Nephrology
• Cardiology
• Endocrinology

Background:

• Diabetic nephropathy presents significant renal and cardiovascular risks.
• Arterial blood pressure, particularly systolic pressure, is a key factor in these outcomes.
• The relationship between blood pressure and outcomes in type 2 diabetic nephropathy requires precise understanding.

Purpose of the Study:

• To evaluate the impact of systolic and diastolic blood pressure on renal and cardiovascular outcomes in type 2 diabetic nephropathy.
• To determine the optimal systolic blood pressure target for risk reduction.
• To assess the safety of aggressive antihypertensive therapy.

Main Methods:

• Observational analysis of patients with type 2 diabetic nephropathy and hypertension.
• Correlation of achieved systolic and diastolic blood pressure levels with renal and cardiovascular events.
• Review of antihypertensive treatment strategies, including angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers.

Main Results:

• Systolic blood pressure is a critical determinant of renal and cardiovascular outcomes.
• Achieving systolic pressures around 120 mm Hg is associated with substantial risk reduction.
• Excessive reduction in diastolic pressure may elevate cardiac event risk.
• A potential J-curve effect suggests increased mortality with systolic pressures below 120 mm Hg.

Conclusions:

• Systolic blood pressure control is paramount in managing type 2 diabetic nephropathy.
• Targeting systolic blood pressure to approximately 120 mm Hg offers significant risk reduction.
• Careful management of diastolic pressure is necessary during aggressive antihypertensive therapy.
• Combination therapy, potentially involving 3 or more agents, may be required for optimal blood pressure control.